You are using an older browser version. Please use a supported version for the best MSN experience.

Pfizer will access Array's approved cancer drugs in $11 billion deal

Dow component Pfizer is buying Array Biopharma for $48 per share in cash, or $11.4 billion.

UP NEXT

UP NEXT

CNBC

Fortune

image beaconimage beaconimage beacon